which would still be an average hypothesis based on a limited amount of data,deduced to an avg which would be avg,not exact
Surely there is a shitkicker bar near you that has a bull-ride machine. It is simultaneouslya buy and a sell.
Out! Well I guess you ought to go and get a full on colonoscopy then NK! That's right the full probe is a thing of the past and this couldn't come fast enough as I'm approaching the 50 barrier. Homey don't go there! Sorry. The EXAS COLOGUARD (snazzy name eh?) detects pre cancer cells almost 60% of the time purely from a butt wipe something we do every morning anyway. Perhaps even more exciting is that COLOGUARD detects Stage 1 cancer 100% of the time... There is a huge part of the medical industrial complex that wants this stock to fail! There is that danger folks! Normally you take a ride like this you might get off and in fact I am thinking along similar lines but what of that break out point $9.80 we are close to that, could we just extend this through the 52 week high and crest out at $12.00? Hummmmm. Maybe this could help- 07 Feb 20:00 EXACT Sciences Corp. at UBS Healthcare Services Conf.... ~stoney
òà êèå ìåëüêèå ëþäè Ãà ýòîì ñà éòå...äåä áû õîòü âûïîëç ÷òî ëè...
Stoney, I've had a core investment in EXAS for over 5 years now. You can do a search and see some posts that I made on ET back in 2007 highlighting this Company. The key is the new management team that came in about 3 years ago. CEO Kevin Conroy and CFO Maneesh Arora and Senior Research Scientist Graham LIdgard are Winners! At their last Company, "Third Wave Technologies" they developed an HPV screening test (Cervista) for cervical cancer. They sold the Company about a year before FDA approval to Hologic (HOLX) for $580 million in 2007.